Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanisms by which systemic salbutamol increases ventilation.

Antony E Tobin1, Anne-Marie Pellizzer, John D Santamaria

  • 1Intensive Care Unit, St Vincent's Hospital, Melbourne, Victoria, Australia. antony.tobin@svhm.org.au

Respirology (Carlton, Vic.)
|March 22, 2006
PubMed
Summary

Intravenous salbutamol (SAL) increases metabolic rate and lactate, potentially worsening ventilation in severe asthma patients. This study quantifies SAL's systemic effects on ventilation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hospital standardised mortality ratio: a novel method and approach to risk adjustment.

BMJ open quality·2026
Same author

Promising solution for standardised length of hospital stay based on time-to-event models and contemporary Australian administrative data.

BMJ open·2025
Same author

Accuracy of continuous glucose monitoring in critically ill patients.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2025
Same author

Critical care outcome prediction equation model, version 7.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2025
Same author

Maternal and Neonatal Outcomes: Right Data, Wrong Methodology, Misleading Answer?

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

A randomised, open-label trial of nebulised unfractionated heparin in patients mechanically ventilated for COVID-19.

Anaesthesia and intensive care·2025

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Critical Care

Background:

  • Systemic administration of salbutamol (SAL) can have adverse effects on ventilation.
  • Understanding these systemic effects is crucial for managing asthmatic patients.

Purpose of the Study:

  • To quantify the impact of intravenous SAL on ventilation.
  • To elucidate the mechanisms underlying SAL-induced ventilatory changes.

Main Methods:

  • Prospective study involving nine healthy subjects receiving intravenous SAL at escalating doses (5, 10, 20 microg/min).
  • Comprehensive monitoring of respiratory parameters (VE, VO2, VCO2, P0.1), metabolic markers (lactate, glucose), and electrolytes (K+).
  • Assessment of ventilatory response to 100% oxygen during SAL infusion.

Related Experiment Videos

Main Results:

  • Intravenous SAL significantly increased minute ventilation (VE), oxygen consumption (VO2), and carbon dioxide production (VCO2) at 20 microg/min.
  • Increased ventilation exceeded metabolic demands, evidenced by a rising respiratory exchange ratio and significant increase in serum lactate, suggesting lactic acidosis.
  • No significant change in VE or P0.1 with 100% oxygen indicated peripheral chemoreceptors were not the primary driver of increased ventilation.

Conclusions:

  • Systemic SAL increases metabolic rate and serum lactate, imposing ventilatory demands.
  • These effects may pose risks for severe asthma patients with compromised respiratory reserve.